About

Dr. Adrian A. Suarez is a leading gynecologic oncologist whose research focuses on refining surgical staging and improving survival outcomes for women with endometrial cancer. His most impactful work centers on sentinel lymph node mapping, where he conducted a landmark prospective clinical trial (NCT01818739) comparing isosulfane blue and indocyanine green for robotic-assisted assessment. This study, cited 76 times, demonstrated the feasibility and accuracy of dual-tracer mapping, particularly when combined with ultrastaging, thereby reducing the need for complete lymphadenectomy and its associated morbidity. Dr. Suarez has also investigated the determinants of surgical approach—including minimally invasive versus open techniques—and their influence on survival, contributing critical data to the ongoing debate about optimal management of endometrial carcinoma. His work has directly shaped clinical guidelines, offering surgeons evidence-based strategies to personalize care while minimizing invasiveness. Through these contributions, Dr. Suarez has established himself as a key figure in advancing the precision and safety of gynecologic oncology surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
93
Total Citations
47
Avg Citations/Paper
🏆 Most Cited Paper
Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739)
76 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago